Engineering mesenchymal stem cells for regenerative medicine and drug delivery

Methods : a Companion to Methods in Enzymology
Ji Sun ParkKam W Leong

Abstract

Researchers have applied mesenchymal stem cells (MSC) to a variety of therapeutic scenarios by harnessing their multipotent, regenerative, and immunosuppressive properties with tropisms toward inflamed, hypoxic, and cancerous sites. Although MSC-based therapies have been shown to be safe and effective to a certain degree, the efficacy remains low in most cases when MSC are applied alone. To enhance their therapeutic efficacy, researchers have equipped MSC with targeted delivery functions using genetic engineering, therapeutic agent incorporation, and cell surface modification. MSC can be genetically modified virally or non-virally to overexpress therapeutic proteins that complement their innate properties. MSC can also be primed with non-peptidic drugs or magnetic nanoparticles for enhanced efficacy and externally regulated targeting, respectively. Furthermore, MSC can be functionalized with targeting moieties to augment their homing toward therapeutic sites using enzymatic modification, chemical conjugation, or non-covalent interactions. These engineering techniques are still works in progress, requiring optimization to improve the therapeutic efficacy and targeting effectiveness while minimizing any loss of MSC function. In t...Continue Reading

References

May 30, 2001·Trends in Molecular Medicine·A I Caplan, S P Bruder
Mar 14, 2007·Stem Cells and Development·Yoshie OzakiYukio Kato
Aug 9, 2007·Advanced Drug Delivery Reviews·Jaspreet K Vasir, Vinod Labhasetwar
Jan 10, 2008·Arthroscopy : the Journal of Arthroscopic & Related Surgery : Official Publication of the Arthroscopy Association of North America and the International Arthroscopy Association·Takaaki KobayashiKoji Arihiro
Jan 29, 2008·Current Stem Cell Research & Therapy·Karen Bieback, Harald Klüter
Nov 4, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Kentaro OtaniNoritoshi Nagaya
Apr 21, 2009·Biomaterials·In Kap KoJames E Dennis
Jun 11, 2009·Seminars in Cell & Developmental Biology·Sarah Sundelacruz, David L Kaplan
Nov 11, 2009·Proteomics·Ajit VarkiMarilynn E Etzler
Aug 17, 2010·Journal of Controlled Release : Official Journal of the Controlled Release Society·Joanna RejmanStefaan C De Smedt
Sep 4, 2010·Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics·Qing-Guo LaiShu Li
Sep 10, 2010·Human Gene Therapy·Conrad P HodgkinsonVictor J Dzau
Oct 29, 2011·Blood·Debanjan SarkarJeffrey M Karp
Nov 4, 2011·Journal of Drug Targeting·Thomas J KeanJames E Dennis
Dec 15, 2012·Biomaterials·Johannes RieglerMark F Lythgoe
Mar 15, 2013·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Miroslaw JanowskiPiotr Walczak
Apr 24, 2013·Chemical Society Reviews·Prathamesh M KharkarApril M Kloxin
May 22, 2013·Recent Patents on Anti-cancer Drug Discovery·Markus D Lacher, Maurizio Provenzano

❮ Previous
Next ❯

Citations

Feb 20, 2016·Nature Reviews. Neuroscience·Vivian BudnikFranz Wendler
Jan 7, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Bruna Corradetti, Mauro Ferrari
Dec 1, 2015·International Journal of Pharmaceutics·E AndréC N Montero-Menei
Apr 6, 2016·Regenerative Biomaterials·Hon Fai ChanKam W Leong
Sep 10, 2015·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·Brigitte AnlikerMatthias Schweizer
Jun 29, 2015·Methods : a Companion to Methods in Enzymology·Gordana Vunjak-Novakovic
Apr 30, 2015·Stem Cells and Development·Ann De Becker, Ivan Van Riet
Jun 24, 2015·Stem Cells International·Xianyun WangBaoyong Yan
Oct 25, 2016·Materials Science & Engineering. C, Materials for Biological Applications·Jingyu YangXingdong Zhang
Jul 17, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Simon LeeFrancis C Szoka
Sep 7, 2016·Stem Cells International·Akalabya BissoyiArindam Bit
Jun 9, 2016·The Journal of Gene Medicine·Simone GabnerMonika Egerbacher
Oct 18, 2016·Cytotherapy·Elizabeth K SageSam M Janes
May 26, 2017·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Rinat Meir, Rachela Popovtzer
Oct 5, 2017·International Journal of Molecular Sciences·Silvia BaldariGabriele Toietta
Mar 30, 2016·World Journal of Stem Cells·Ann De Becker, Ivan Van Riet
Mar 23, 2019·Expert Opinion on Biological Therapy·Nina KosaricGeoffrey C Gurtner
Feb 20, 2018·Artificial Cells, Nanomedicine, and Biotechnology·Shunxiu CaoLiang Jin
Jun 9, 2019·The Journal of Pharmacology and Experimental Therapeutics·Shen ChengSwayam Prabha
Aug 14, 2019·Advanced Science·Huize YanKam W Leong
Jan 26, 2020·International Journal of Molecular Sciences·Hyeon Su JooJung Min Lee
Feb 13, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Paz de la TorreAna I Flores
Feb 26, 2020·Nanomaterials·Itziar Gómez-AguadoAna Del Pozo-Rodríguez
May 23, 2020·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Jessica C HsuDavid P Cormode
Jan 13, 2018·International Journal of Molecular Medicine·Marina DevetziVassilis Zoumpourlis
May 20, 2017·Oncology Letters·Junyi WuChun-Ping Jiang
Dec 2, 2017·Biotechnology Journal·Ahmed Abdal DayemSsang-Goo Cho
Dec 18, 2019·Stem Cell Research & Therapy·Jibin HanYuanyuan Li
Apr 11, 2020·Drug Design, Development and Therapy·Wen-Bo NieLi-Sheng Wang
Jul 17, 2020·Stem Cell Reviews and Reports·Amir K VarkouhiClaudia C Dos Santos
Jun 1, 2018·World Journal of Stem Cells·Luminita LabuscaKaveh Mashayekhi
Sep 19, 2017·Tissue Engineering and Regenerative Medicine·Asieh Heirani-TabasiHojjat Naderi-Meshkin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.